Abstract:Mitochondria are vital for cellular functions, including metabolism, calcium buffering and apoptosis regulation. Cardiolipin (CL), a key phospholipid in the inner mitochondrial membrane (IMM), maintains mitochondrial integrity and supports oxidative phosphorylation (OXPHOS). CL also regulates cytochrome c release, linking it to apoptotic pathways. Amyloidogenic peptides like amyloid‐β, tau and α‐synuclein disrupt mitochondria by forming ion‐conducting pores, leading to cell death. CL enhances amyloid toxicity by promoting membrane insertion and pore formation. Additionally, other peptides, including Bcl‐2 family members and toxins, also damage mitochondrial membranes, highlighting the need to study CL–amyloid interactions to prevent dysfunction. Mitochondria are essential organelles known to serve broad functions, including in cellular metabolism, calcium buffering, signaling pathways and the regulation of apoptotic cell death. Maintaining the integrity of the outer (OMM) and inner mitochondrial membranes (IMM) is vital for mitochondrial health. Cardiolipin (CL), a unique dimeric glycerophospholipid, is the signature lipid of energy‐converting membranes. It plays a significant role in maintaining mitochondrial architecture and function, stabilizing protein complexes and facilitating efficient oxidative phosphorylation (OXPHOS) whilst regulating cytochrome c release from mitochondria. CL is especially enriched in the IMM and at sites of contact between the OMM and IMM. Disorders of protein misfolding, such as Alzheimer's and Parkinson's diseases, involve amyloidogenic peptides like amyloid‐β, tau and α‐synuclein, which form metastable toxic oligomeric species that interact with biological membranes. Electrophysiological studies have shown that these oligomers form ion‐conducting nanopores in membranes mimicking the IMM's phospholipid composition. Poration of mitochondrial membranes disrupts the ionic balance, causing osmotic swelling, loss of the voltage potential across the IMM, release of pro‐apoptogenic factors, and leads to cell death. The interaction between CL and amyloid oligomers appears to favour their membrane insertion and pore formation, directly implicating CL in amyloid toxicity. Additionally, pore formation in mitochondrial membranes is not limited to amyloid proteins and peptides; other biological peptides, as diverse as the pro‐apoptotic Bcl‐2 family members, gasdermin proteins, cobra venom cardiotoxins and bacterial pathogenic toxins, have all been described to punch holes in mitochondria, contributing to cell death processes. Collectively, these findings underscore the vulnerability of mitochondria and the involvement of CL in various pathogenic mechanisms, emphasizing the need for further research on targeting CL‐amyloid interactions to mitigate mitochondrial dysfunction.

Cardiolipin is required for membrane docking of mitochondrial ribosomes and protein synthesis

The Role Of Cardiolipin In Cardiovascular Health

Cardiolipin Remodeling: a Regulatory Hub for Modulating Cardiolipin Metabolism and Function

Cardiolipin-deficient cells have decreased levels of the iron-sulfur biogenesis protein frataxin

Deletion of the Cardiolipin‐specific Phospholipase Cld1 Rescues Growth and Lifespan Defects in the Tafazzin Mutant: Implications for Barth Syndrome (605.4)

Cardiolipin clustering promotes mitochondrial membrane dynamics

Deletion of the Cardiolipin-specific Phospholipase Cld1 Rescues Growth and Life Span Defects in the Tafazzin Mutant: IMPLICATIONS FOR BARTH SYNDROME

Role of Cardiolipin in Mitochondrial Function and Dynamics in Health and Disease: Molecular and Pharmacological Aspects

Cardiolipin remodeling maintains the inner mitochondrial membrane in cells with saturated lipidomes

Cardiolipin, and not monolysocardiolipin, preferentially binds to the interface of complexes III and IV

Mitoregulin supports mitochondrial membrane integrity and protects against cardiac ischemia-reperfusion injury

Cardiolipin deficiency leads to decreased cardiolipin peroxidation and increased resistance of cells to apoptosis.

Role of cardiolipin in regulating and treating atherosclerotic cardiovascular diseases

The Role of Cardiolipin in Mitochondrial Function and Neurodegenerative Diseases

Poration of mitochondrial membranes by amyloidogenic peptides and other biological toxins

A Requirement for Cardiolipin in the Organization and Function of Mitochondrial Supercomplexes

Structural insights into cardiolipin replacement by phosphatidylglycerol in a cardiolipin-lacking yeast respiratory supercomplex

The Role of Cardiolipin in Brain Bioenergetics, Neuroinflammation, and Neurodegeneration

Unraveling the mechanisms of cardiolipin function: The role of oxidative polymerization of unsaturated acyl chains

Perturbations in mitochondrial metabolism associated with defective cardiolipin biosynthesis: An real-time NMR study

Hepatic LDL receptor-related protein-1 deficiency alters mitochondrial dynamics through phosphatidylinositol 4,5-bisphosphate reduction